Synlogic Inc. (SYBX) Financial Statements (2024 and earlier)

Company Profile

Business Address 301 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:077,600136,600100,400119,600122,700
Cash and cash equivalents23,96015,86116,43832,50726,18411,252
Short-term investments23,78661,768112,15067,93793,387111,477
Other undisclosed cash, cash equivalents, and short-term investments(47,746)(29)8,012(44)29(29)
Prepaid expense1,2271,6581,6891,3841,0381,099
Asset, held-for-sale, not part of disposal group      
Other current assets146175311247648388
Other undisclosed current assets48,534349(5,291)4,81511,960151
Total current assets:49,90779,782133,309106,846133,246124,338
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization     900
Operating lease, right-of-use asset 12,10214,35613,88915,52717,263
Property, plant and equipment 5,6037,3239,08810,77613,02114,841
Long-term investments and receivables   8,041 15,002 
Long-term investments   8,041 15,002 
Restricted cash and investments1,0971,0971,0971,0971,0971,097
Other noncurrent assets167346464
Other undisclosed noncurrent assets 6,8258,3009,3099,5907,981 
Total noncurrent assets:25,64331,08341,42736,99455,32816,002
TOTAL ASSETS:75,550110,865174,736143,840188,574140,340
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,4577,0756,3465,7686,1117,414
Accounts payable1,4571,7851,9441,9952,1652,380
Accrued liabilities3,0005,2904,4023,7733,9465,034
Deferred revenue  882531 544
Debt4131222,208266
Deferred rent credit      393
Contract with customer, liability268
Other undisclosed current liabilities15,9434,1523,1912,531  
Total current liabilities:20,40412,12210,0808,3018,8638,341
Noncurrent Liabilities
Long-term debt and lease obligation  417,39020,27322,806210
Capital lease obligations210
Finance lease, liability  418 2
Liabilities, other than long-term debt12,49116,129 131 7,691
Deferred rent credit      7,691
Other liabilities    131  
Operating lease, liability12,49116,12917,37220,27322,804
Other undisclosed noncurrent liabilities   (17,372)   
Total noncurrent liabilities:12,49116,13317,39020,40422,8067,901
Total liabilities:32,89528,25527,47028,70531,66916,242
Equity
Equity, attributable to parent42,65582,610147,266115,135156,905124,098
Common stock107170383325
Treasury stock, value(2,518)(2,518)    
Additional paid in capital459,458442,237438,113345,394327,900243,903
Accumulated other comprehensive income (loss) 6(161)(45)14110(65)
Accumulated deficit(414,301)(357,019)(290,872)(230,311)(171,138)(119,765)
Total equity:42,65582,610147,266115,135156,905124,098
TOTAL LIABILITIES AND EQUITY:75,550110,865174,736143,840188,574140,340

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues3,3711,1801,7545452,2242,520
Gross profit:3,3711,1801,7545452,2242,520
Operating expenses(58,532)(68,599)(62,519)(61,011)(56,633)(53,750)
Operating loss:(55,161)(67,419)(60,765)(60,466)(54,409)(51,230)
Nonoperating income (expense)(2,107)1,2722041,2933,0362,795
Investment income, nonoperating2,4691,2672101,3023,0622,843
Other nonoperating income (expense)(517)7(4)(3)(5)(5)
Interest and debt expense (1)(2)(2)(6)(21)(43)
Loss from continuing operations before equity method investments, income taxes:(57,269)(66,149)(60,563)(59,179)(51,394)(48,478)
Other undisclosed income from continuing operations before income taxes 1     
Loss from continuing operations before income taxes:(57,268)(66,149)(60,563)(59,179)(51,394)(48,478)
Income tax expense(14)    (33)
Loss from continuing operations:(57,282)(66,149)(60,563)(59,179)(51,394)(48,511)
Loss before gain (loss) on sale of properties:(60,563)(59,179)(51,394)(48,511)
Other undisclosed net income  2262176
Net loss available to common stockholders, diluted:(57,282)(66,147)(60,561)(59,173)(51,373)(48,435)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(57,282)(66,147)(60,561)(59,173)(51,373)(48,435)
Comprehensive loss:(57,282)(66,147)(60,561)(59,173)(51,373)(48,435)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent167(116)(59)(96)175(56)
Comprehensive loss, net of tax, attributable to parent:(57,115)(66,263)(60,620)(59,269)(51,198)(48,491)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: